Search bioRxiv⌕ Search

bioRxiv · 10.1101/817650

State Change Probability: A Measure of the Complexity of Cardiac RR Interval Time Series Using Physiological State Change with Statistical Hypothesis Testing

Abstract

The complexity of biological signals has been proposed to reflect the adaptability of a given biological system to different environments. Two measures of complexity--multiscale entropy (MSE) and entropy of entropy (EoE)--have been proposed, to evaluate the complexity of heart rate signals from different perspectives. The MSE evaluates the information content of a long time series across multiple temporal scales, while the EoE characterizes variation in amount of information, which is interpreted as the \"state changing,\" of segments in a time series. However, both are problematic when analyzing white noise and are sensitive to data size. Therefore, based on the concept of \"state changing,\" we propose state change probability (SCP) as a measure of complexity. SCP utilizes a statistical hypothesis test to determine the physiological state changes between two consecutive segments in heart rate signals. The SCP value is defined as the ratio of the number of state changes to total number of consecutive segment pairs. Two common statistical tests, the t-test and Wilcoxon rank-sum test, were separately used in the SCP algorithm for comparison, yielding similar results. The SCP method is capable of reasonably evaluating the complexity of white noise and other signals, including 1/f noise, periodic signals, and heart rate signals, from healthy subjects, as well as subjects with congestive heart failure or atrial fibrillation. The SCP method is also insensitive to data size. A universal SCP threshold value can be applied, to differentiate between healthy and pathological subjects for data sizes ranging from 100 to 10,000 points. The SCP algorithm is slightly better than the EoE method when differentiating between subjects, and is superior to the MSE method.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chao, H.-H., Huang, H.-P., Wei, S.-Y., Hsu, C. F., Hsu, L., Chi, S.. 2019-10-24. State Change Probability: A Measure of the Complexity of Cardiac RR Interval Time Series Using Physiological State Change with Statistical Hypothesis Testing. https://doi.org/10.1101/817650

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗